Stenting versus medical treatment alone for symptomatic intracranial artery stenosis: a preplanned pooled individual patient data analysis

医学 冲程(发动机) 狭窄 内科学 随机对照试验 血管成形术 经皮 高脂血症 外科 糖尿病 机械工程 工程类 内分泌学
作者
Tao Wang,Jichang Luo,Tianhua Li,Eyad Almallouhi,Peng Gao,Haozhi Gong,Xiao Zhang,Jie Wang,Taoyuan Lu,Yifan Yang,Renjie Yang,Zixuan Xing,Haibo Wang,Colin P. Derdeyn,Liqun Jiao
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:: jnis-022189
标识
DOI:10.1136/jnis-2024-022189
摘要

Background Whether the safety and efficacy of percutaneous transluminal angioplasty and stenting (PTAS) is significantly different from that of medical treatment alone for symptomatic intracranial arterial stenosis (ICAS) is debatable. A study was undertaken to determine the safety and efficacy of both treatments for symptomatic ICAS. Methods This preplanned pooled individual patient data analysis included 400 participants treated with PTAS and 409 treated with medical treatment alone in two large multicenter randomized clinical trials (SAMMPRIS and CASSISS). Patients were treated with PTAS using a self-expanding stent or medical treatment alone. The primary outcome was stroke or death within 30 days, or ischemic stroke in the territory of the qualifying artery more than 30 days after enrollment. Results Individual data were obtained for 809 patients, 451 from SAMMPRIS and 358 from CASSISS. 400 participants were randomly assigned to the PTAS group and 409 to the medical group. The risk of the primary outcome was not significant between the PTAS and medical groups (17.5% vs 13.2%; HR 1.37 (95% CI 0.96 to 1.95), P=0.08). However, the risk of stroke or death within 30 days was higher in the PTAS group (10.5% vs 4.2%; HR 2.62 (95% CI 1.49 to 4.61), P<0.001). Patients of white ethnicity (HR 1.97, 95% CI 1.17 to 3.31) and those with hyperlipidemia (HR 2.04, 95% CI 1.27 to 3.26) or a transient ischemic attack (TIA) (HR 2.19, 95% CI 1.08 to 4.45) were at higher risk for PTAS. Conclusions PTAS poses an increased risk of short-term stroke/death and therefore is not advised as primary treatment for symptomatic ICAS. A balance exists between stroke risks and revascularization benefits. For patients with asymptomatic ICAS of white ethnicity and those with hyperlipidemia or a history of TIA, a thorough assessment is warranted before considering PTAS. Trial registration ClinicalTrials.gov Identifier: NCT00576693 , NCT01763320 .
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
haoliu发布了新的文献求助80
1秒前
LL应助renxiaoting采纳,获得10
1秒前
paulmichael发布了新的文献求助20
3秒前
CNS天天有发布了新的文献求助10
4秒前
科研通AI5应助一往之前采纳,获得10
4秒前
4秒前
5秒前
刻苦安双完成签到,获得积分10
6秒前
科研通AI2S应助岳霖风采纳,获得10
7秒前
小玉应助柚子采纳,获得10
8秒前
8秒前
9秒前
yanglina062发布了新的文献求助10
9秒前
香蕉觅云应助zyy采纳,获得10
9秒前
小二郎应助雪山飞鹰采纳,获得10
9秒前
研友_VZG7GZ应助kdjm688采纳,获得10
9秒前
天天快乐应助节律之神采纳,获得10
10秒前
Ava应助墨墨采纳,获得10
11秒前
科研通AI5应助周游采纳,获得10
13秒前
13秒前
脑洞疼应助科研通管家采纳,获得10
13秒前
今后应助科研通管家采纳,获得10
14秒前
14秒前
AlinaLee应助科研通管家采纳,获得10
14秒前
在水一方应助科研通管家采纳,获得10
14秒前
小二郎应助科研通管家采纳,获得30
14秒前
852应助科研通管家采纳,获得10
14秒前
lululuao完成签到,获得积分10
14秒前
Orange应助科研通管家采纳,获得10
14秒前
Hello应助科研通管家采纳,获得10
14秒前
max应助科研通管家采纳,获得20
14秒前
柒月应助科研通管家采纳,获得30
14秒前
Akim应助科研通管家采纳,获得10
14秒前
天天快乐应助科研通管家采纳,获得10
14秒前
小二郎应助科研通管家采纳,获得10
14秒前
烟花应助科研通管家采纳,获得10
14秒前
大模型应助科研通管家采纳,获得10
14秒前
小蘑菇应助科研通管家采纳,获得10
15秒前
max应助科研通管家采纳,获得20
15秒前
ding应助科研通管家采纳,获得10
15秒前
高分求助中
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children 5th Edition 2000
IZELTABART TAPATANSINE 500
Where and how to use plate heat exchangers 500
Seven new species of the Palaearctic Lauxaniidae and Asteiidae (Diptera) 400
Armour of the english knight 1400-1450 300
Handbook of Laboratory Animal Science 300
Not Equal : Towards an International Law of Finance 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3712158
求助须知:如何正确求助?哪些是违规求助? 3260326
关于积分的说明 9913708
捐赠科研通 2973659
什么是DOI,文献DOI怎么找? 1630756
邀请新用户注册赠送积分活动 773579
科研通“疑难数据库(出版商)”最低求助积分说明 744314